New tool aims to make opioid tapering safer and less scary
NCT ID NCT07202026
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to create a decision aid to help patients on long-term opioid therapy and their doctors have better conversations about safely reducing or stopping opioids. Researchers will interview patients and doctors to understand their experiences, then test the tool with 30 patients. The goal is to reduce fear, improve trust, and avoid harms like untreated pain or relapse to illicit opioids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Patient-centered Decision Aid (behavioral intervention)
What this could lead to
If successful, this could lead to a tool that helps patients and doctors have better conversations about safely reducing opioid use, potentially reducing harm from forced tapering.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply to everyone. The decision aid may not work as well in real-world settings or for diverse populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, 98101, United States